$BNTX (-3,93 %) has taken quite a beating in pre-market trading today. R.F. Kennedy and Peter Marks (FDA) have parted ways following differences of opinion on the subject of vaccinations. The vaccine values such as $BNTX (-3,93 %) and $MRNA (-6,62 %) have suffered. For me, this is a good opportunity to add to my BionTech position right after the US IPO - I am speculating on a breakthrough in the oncology pipeline in 2026. Biontech is one of my long term swings.

In addition to Biontech, I also added to my $RDC (-0,08 %) Shopapotheke position again today.

$RDC (-0,08 %) A good start for risk-taking traders

@Dividenden_Monteur wouldn't that be for you - a leveraged long? 😁

$UBER (-5,47 %) traded in the small range. the next buy order in the lower part of the range is already in again. Every little helps a lot👆

PS: This has no relevance for B&H investors - in the long term, Uber is a good buy even at this level!

The capital that was freed up went into the $RDC (-0,08 %) This position was reduced by 2/3 / profits taken after the earnings a few days ago. Also hit a small resistance zone at around €123.

$RDC (-0,08 %) The reaction to the quarterly figures then came as desired. It's nice when a trade works out as planned, but of course that's not always the case! Part of the position was already reduced on the day of earnings, and another part was reduced today at €139.20. I'm letting a third of the position (30 shares) run a little longer in case something happens 🤷‍♂️

The $RDC (-0,08 %) has been moving quite stably in a nice channel for about a year and "swings" up and down - almost like in the textbook in the VWAP (Volume Weighted Average Price) within the standard deviation _1.

70% of the volume has been traded within this range in the last 12 months, so buyers/sellers are liquid. Let's hope they don't change their behavior 😁

I'm speculating that the share price will return to the lower edge, which can then move up again in time for the next quarterly figures on May 6. So, friends of Shopapotheke - save the date👆

$NKE (-9,93 %) After Nike has been on my watchlist for several weeks, the time had come this week. A first position of 80 shares has been opened 😁

If you zoom back to 2019 at weekly level, the current range has proven to be support. The VRVP (Visible Range Volume Profile - visible in the chart on the left) has also reached the lower edge of liquidity. The SMA 50, 100 and 200 are also much higher than the current range.

Zooming into the "now and today" area reveals a similar picture. The current range has been tested several times since July 2024.

An entry shortly before the figures is of course always associated with some risk, but without risk there is no return. A bit of crystal ball gazing at the end 😉

My crystal ball has led me to the following assumption - I expect an upward breakout. If it breaks out downwards into the risk area as shown in the following chart, then the stop loss will have to do its job. You only know afterwards 😂

Who is also invested in Nike or recently got in at this level? How do you see the rest of 2025 for Nike?

PS: For those who follow my posts - $RDC (-0,08 %) is running as expected, I sold a small amount on the day of the numbers after the strong rise (TP1), the remaining position with 70 shares is still running. https://getqu.in/LcDiWw/

With $UBER (-5,47 %) I also re-entered this week after my exit a month ago https://getqu.in/Qw3pDX/

Let's see what happens 😎

Tesla shares fall by more than 15 percent in one day + Tonner drones accelerate commercial development of INHIBITOR solution + Redcare hopes for strong sales growth + Henkel to invest one billion euros in share buyback + Deutsche Börse at record high + Apple has to work longer on new AI-Siri

Tesla share $TSLA (-3,59 %)falls by more than 15 percent in one day

• The share price of Tesla, the electric car manufacturer led by Elon Musk, fell by more than 15 percent to 222 dollars on Monday, thus losing the last gains made after the US presidential election in November.
• Prior to the accelerated share price losses on Monday, another analyst had lowered the forecast for Tesla deliveries.
• The share price fell a further three percent after the close of trading.
• Since the record high in mid-December, the drop now amounts to more than 50 percent.
• Musk had become a close ally of the ultimately victorious Republican Donald Trump during the US election campaign.
• Following his triumph in the presidential election, Tesla shares soared.
• At its peak in mid-December, it was worth around twice as much as on election day on November 4.
• A downward slide then set in, which recently became steeper.
• After the share price plummeted, Trump claimed that "radical left-wing lunatics" were boycotting Tesla in order to harm Musk.
• He would buy a Tesla car on Tuesday as a sign of support for the "great American" Musk, the US President announced via the online platform Truth Social.

Tonner drones $ALDR (+8,9 %)accelerates the commercial development of the INHIBITOR solution

• Tonner Drones ("the Company") announces that it is intensifying its efforts to commercialize its Inhibitor product.
• Tonner Drones holds valuable patents for stabilizing drones and counteracting the recoil effect.
• This technology can significantly improve the operation of drones after a target has been shot down.
• In light of the global increase in defense spending, Tonner Drones would like to take this opportunity to generate interest in the inhibitor patents from the parties.
• While Tonner Drones itself has no ambitions to develop the product, the company aims to optimize the value of the patents through sales or licensing agreements.

Redcare $RDC (-0,08 %)hopes for strong sales growth

• The online pharmacy Redcare Pharmacy (formerly Shop Apotheke) is also aiming for strong growth in the current year.
• The MDax-listed company announced in Sevenum on Tuesday that sales are set to increase by at least a quarter.
• Based on sales of just under 2.4 billion euros last year, this would be 3.0 billion euros in the worst-case scenario, which is roughly what analysts surveyed by Bloomberg have in mind.
• In terms of profitability, however, the Dutch company could possibly disappoint again: The margin for adjusted earnings before interest, taxes, depreciation and amortization (ber EBITDA) is expected to improve slightly to between 2 and 2.5 percent.
• Analysts currently expect 2.3 percent. Redcare had already announced turnover figures in January.
• These have now been confirmed. The adjusted operating result fell by more than a third to 33.3 million euros, with the margin more than halving to 1.4 percent.
• The market had been expecting a less severe decline.
• In the final quarter, Redcare was even in the red in its day-to-day business.
• And the bottom line for shareholders in 2024 was again a loss: it increased to 45 million euros, compared to minus 12 million euros in 2023.

Henkel $HEN (+1,69 %)wants to invest one billion euros in share buyback

• The consumer goods group Henkel has announced that it will buy back its own shares for up to one billion euros.
• The Dax-listed preference shares worth up to 800 million euros are to be acquired, as the company announced on Tuesday shortly before the announced presentation of the annual figures in Düsseldorf.
• The remaining 200 million euros are to be invested in the purchase of ordinary shares.
• "Based on the current share price, this corresponds to around 2.7 percent of the company's share capital."
• Henkel shares have significantly lagged behind the DAX in recent years.
• The company currently has a market capitalization of just under 36 billion euros.

German stock exchange $DB1 (+2,06 %)at record high

• In a weak overall market, Deutsche Börse shares reached another record high on Monday.
• The increasing price fluctuations on the financial markets are likely to keep investors on their toes and ensure good turnover for stock exchange operators.
• The shares of the stock exchange operator rose by 2.9 percent to 264.80 euros at the peak in the afternoon.
• Deutsche Börse shares have climbed by almost 20 percent since the beginning of the year.
• The shares of counterparty Euronext had reached a high on Thursday.
• Not least the political developments since the election of Donald Trump as US President and his erratic actions are likely to force investors to constantly adjust their portfolios - with positive consequences for exchange operators.
• According to analyst Jochen Schmitt from Metzler Bank, turnover in interest rate products on the Eurex derivatives exchange and in cash trading on Xetra increased in January and February compared to the previous year.
• Deutsche Börse should benefit from the favorable capital market environment.
• Economies of scale would benefit the results, as the cost base is strongly determined by fixed costs.

Apple $AAPL (-6,25 %)has to work longer on new AI-Siri

• Setback for Apple in the AI race with other tech giants: The iPhone company is taking longer than planned to develop its improved assistance software Siri.
• The new far-reaching functions with artificial intelligence will not be available until "next year", an Apple spokesperson told the website "Daring Fireball".
• The function was generally expected to be available this spring.
• Apple's plan is for the future Siri to be particularly helpful for users because the software has access to users' personal information and can be active across different apps.
• Rivals such as Google and Samsung also want to establish such functions in the everyday lives of users of their devices and software.
• Amazon will soon be opening advance access to an AI version of its Alexa assistance software in the USA. Apple has summarized its new AI offerings under the name "Apple Intelligence".
• So far, the software can reword and summarize texts and create new emoji from user descriptions, among other things.
• The first functions of "Apple Intelligence" are set to appear in Germany in April.
• The company is focusing on AI functions in the marketing of its current iPhone generation.

Tuesday: Stock market dates, economic data, quarterly figures

• ex-dividend of individual stocks
• Novartis CHF 3.50
• Qantas Airways 0.10 AUD
• Spire 0.79 USD

• Quarterly figures / company dates USA / Asia
• 19:00 Eaton Investor Conference Call

• Quarterly figures / company dates Europe
• 06:45 Redcare Pharmacy NV, annual results
• 07:30 Gea Group | Henkel | Volkswagen annual results
• 09:00 Henkel Analyst Conference
• 09:30 Gea Group | Volkswagen BI-PK
• 11:00 Henkel BI-PK

Economic data

01:50 JP: GDP (2nd release) 4Q FORECAST: n.a. 1st release: +0.7% yoy previous: +0.4% yoy

08:00 DE: Labor Cost Index 4Q

15:00 US: Job Openings and Labor Turnover Survey (Jolts) January

No time specified:

- BE: Ecofin meeting of EU finance ministers

- CN: China's People's Congress, closing

$RDC (-0,08 %) is also in an interesting range from a technical perspective. The price is currently hovering around the 50 GLD. (121€). The distance or the way up to the 100 (€135) and 200 (€130) is not uninteresting for swing traders😁

The area of greatest liquidity around €117 has often been a good support in the last 12 months.

Opportunities are the good growth potential through the e-prescription, risk of Amazon's possible entry into the "pharmacy and beauty" sector.

I'm in with a position of 90 shares with a buy-in of €116.77. As they say here - let's see what happens... 😅

World's largest battery manufacturer CATL plans mega IPO + Siemens with jump in profits + Redcare and DocMorris weak because of renewed fear of Amazon + Tesla with stabilization approach after series of losses + Thyssenkrupp lowers sales forecast and focuses on marine industry + US inflation rate rises surprisingly

World's largest battery manufacturer CATL plans mega IPO

• Chinese battery manufacturer Contemporary Amperex Technology (CATL) is on the verge of a mega IPO.
• The world's largest manufacturer of e-car batteries submitted the corresponding application to the Hong Kong Stock Exchange HKEX on Wednesday, confirming rumors of a secondary listing that have persisted for some time.
• The company from the southern Chinese city of Ningde is already listed on the Shenzhen stock exchange.
• As the news agency Bloomberg reported, CATL could now raise more than five billion US dollars with the listing in Hong Kong.
• The battery company intends to use this money primarily to finance investments in the plant currently under construction in Hungary, according to the listing prospectus.
• https://www.handelsblatt.com/unternehmen/industrie/elektromobilitaet-weltgroesster-batteriehersteller-catl-plant-mega-boersengang/100107367.html

Siemens $SIE (-7,02 %)with jump in profits but automation continues to weaken

• Thanks to the sale of its subsidiary Innomotics, the technology group Siemens earned significantly more at the start of the year.
• Earnings after tax rose to 3.9 billion euros in the three months to the end of December, as the company announced in Munich on Thursday.
• Siemens received 3.1 billion euros from the sale.
• In the previous year, the profit amounted to just under 2.6 billion euros.
• In operational terms, however, Siemens recorded a decline due to the continuing weakness in the automation business.
• The result of the industrial business fell by eight percent to 2.5 billion euros.
• The largest contributions to earnings came from the intelligent infrastructure (SI) business and the medical technology subsidiary Siemens Healthineers .
• On a comparable basis, sales rose by three percent to just under 18.4 billion euros.
• This figure excludes currency and portfolio effects.
• Siemens performed slightly better than analysts expected for both key figures.
• The Group confirmed its forecast for the year.

Redcare $RDC (-0,08 %)and DocMorris $DOCM (+2,87 %)weak because fear of Amazon again $AMZN (-6,32 %)

• New concerns about powerful competition from Amazon briefly put more pressure on the shares of Redcare Pharmacy and DocMorris on Wednesday afternoon.
• At times, Redcare fell by 4 percent to its low for the year.
• Most recently, it traded at 115.50 euros again, down just under 3 percent.
• DocMorris fell by a good 2 percent in Zurich.
• The reason for this was probably UBS expert Olivier Clavet's comment on the opening of the "Amazon Parafarmacia & Beauty" in Milan city center.
• Although the move itself is relatively insignificant, the license and the intention to expand into beauty and personal care products are not.
• According to Calvet, Redcare does not break down the share within non-prescription products.
• However, he believes that the Beauty and Personal Care (BPC) business is an important earnings driver

Tesla $TSLA (-3,59 %)
with stabilization approach after series of losses

• Tesla shares rose noticeably on Wednesday after five consecutive days of weak trading.
• Most recently, the shares were up 3.6 percent at 340.25 US dollars.
• Traders referred to a positive analyst study.
• The experts at Benchmark Research gave the shares a "buy" rating and a target price of 475 dollars.
• Autonomous driving and robotics are seen as growth drivers, as is the further market penetration of electric vehicles.
• Since the presentation of disappointing quarterly figures at the end of January, the shares of the electric car manufacturer led by tech billionaire Elon Musk have lost more than 22% at their peak.
• For the year to date, this still represents a drop of around 16 percent.
• Tesla missed Wall Street's expectations with its sales and earnings figures for the past quarter. In the previous year, the e-car manufacturer had also suffered its first decline in deliveries for more than a decade.
• Musk himself said that he sees Tesla "between two waves of growth".
• He is focusing primarily on autonomous driving technology and presented the prototype of a robotaxi without a steering wheel or pedals in October.
• Since the election of Donald Trump as the new US president at the beginning of November, Tesla shares have been virtually unstoppable and had been rushing from record to record by mid-December.
• This resulted in an annual gain of more than 60 percent.
• Major shareholder Musk had strongly supported Trump during the US election campaign and has since been considered one of the future president's most influential advisors.
• Tesla investors are primarily hoping that the car manufacturer will receive approval for more far-reaching autonomous driving more quickly under Trump.
• Critics of Tesla point to the industry pioneer's ageing model range.

US inflation rate rises surprisingly - to 3.0 percent

• US inflation rose surprisingly at the start of the year.
• Consumer prices rose by 3.0% year-on-year in January, faster than the 2.9% increase in December.
• This was announced by the Department of Labor in Washington on Wednesday.
• Economists polled by Reuters had also expected 2.9 percent for January.
• From December to January, prices rose by 0.5 percent.
• Experts had only expected an increase of 0.3 percent.
• The US Federal Reserve, which is supposed to ensure stable prices and promote full employment, recently left the key interest rate in the range of 4.25 to 4.50 percent.
• This ended, for the time being, the series of cuts that began in September.
• When pausing interest rates, the central bank referred to the increased pace of price rises.
• As Fed Chairman Jerome Powell recently confirmed, the US monetary authorities are in no hurry to lower interest rates further in view of the healthy economy.
• They also want to wait and see what economic consequences the policy of punitive tariffs introduced by US President Donald Trump will have.
• Tariff hurdles harbor a new inflation risk, as they are likely to make imports from the countries affected more expensive.
• According to experts, the sharp rise in the cost of living in the USA in recent years is one of the reasons why Trump is likely to win the White House again on 20 January.
• Trump was able to move into the White House again on January 20.

Thyssenkrupp $TKA (-1,73 %)lowers sales forecast due to weak demand and the ray of hope is the marine industry

• The industrial group Thyssenkrupp has had a mixed start to the year.
• Demand in the steel and automotive business as well as in trading remained rather weak.
• One bright spot was the marine business, which grew significantly.
• New business in particular developed strongly, as Thyssenkrupp announced in Essen on Thursday.
• Group CEO Miguel López wants to spin off the division.
• Work is continuing "at full speed" on the spin-off "in order to position the business in the best possible way to process the high order backlog and the continuing high level of customer interest in view of the changed security policy environment", he said when publishing the quarterly figures.
• In the three months to the end of December, thyssenkrupp's sales fell by four percent to 7.8 billion euros, which was significantly below expectations.
• In addition to weak demand, lower steel prices also had a negative impact.
• Adjusted earnings before interest and taxes, on the other hand, rose from 84 million to 191 million euros, which was a positive surprise.
• The company benefited from the ongoing restructuring program as well as lower raw material and energy prices.
• Above all, the profitability of the steel business increased.
• On the bottom line, thyssenkrupp posted a loss of 51 million euros and thus performed significantly better than in the same quarter of the previous year, when a loss of 314 million euros was also incurred due to depreciation and amortization.
• Thyssenkrupp lowered its sales forecast for the current financial year 2024/25 due to weak demand and now expects a range of minus three to 0 percent.
• Previously, the company had assumed a range of 0 to plus three percent.
• However, the earnings forecasts were confirmed.
• Due to advance payments in connection with a comprehensive order extension for four submarines at Marine Systems, thyssenkrupp raised its expectations for the cash inflow, which was widely observed by analysts.
• Free cash flow before mergers and acquisitions is expected to reach up to 300 million euros.
• The company had previously forecast an outflow of 200 to 400 million euros.
• Analysts had previously expected a cash inflow of 100 million euros.

Thursday: Stock market dates, economic data, quarterly figures

• ex-dividend of individual stocks
• Shell USD 0.36
• Equinor NOK 0.35

• Quarterly figures / company dates USA / Asia
• 07:30 Sony annual result
• 08:00 Honda Motor annual results
• 09:25 Nissan quarterly figures
• 12:30 GE Healthcare annual results
• 13:00 Altice quarterly figures
• 21:00 Airbnb annual results
• No time specified: Deere & Co | Baxter International | Applied Materials Quarterly figures

• Quarterly figures / Company dates Europe
• 07:00 Siemens | Thyssenkrupp | Thyssenkrupp Nucera | Nestle | Commerzbank | Schott Pharma | DSM-Firmenich | Bertrandt | KWS Saat | Takkt Annual results
• 07:00 Fraport traffic figures January
• 07:30 Adyen | Douglas | MVV Energie | Orange Annual Results | Delivery Trading Update 4Q | Siemens PK
• 08:00 Barclays Annual Results | British American Tobacco | Unilever | Relx Annual Results
• 08:30 Siemens Analyst Conference
• 09:00 Nestle PK | Commerzbank Analyst Conference
• 10:00 Siemens AGM
• 10:30 Nestle Analyst Conference | Commerzbank BI-PK
• 11:00 Schott Pharma Analyst Conference | Thyssenkrupp Analyst and Press Conference
• 14:30 Commerzbank Capital Markets Day

• Economic data

08:00 DE: Consumer prices (final) January PROGNOSE: -0.2% yoy/+2.3% yoy Preliminary: -0.2% yoy/+2.3% yoy Previous: +0.5% yoy/+2.6% yoy HICP PROGNOSE: -0.2% yoy/+2.8% yoy Preliminary: -0.2% yoy/+2.8% yoy Previous: +0.7% yoy/+2.8% yoy

08:00 UK: GDP (1st release) 4Q FORECAST: 0.0% yoy/+1.2% yoy Q3: +0.1% yoy/+1.0% yoy | GDP month December | Trade Balance December | Industrial Production December

08:30 CH: Consumer prices January FORECAST: +0.4% yoy previously: +0.6% yoy

11:00 EU: Industrial Production December Eurozone OUTLOOK: -0.5% yoy/-3.6% yoy previously: +0.2% yoy/-1.9% yoy

14:30 US: Initial jobless claims (week) FORECAST: 215,000 previous: 219,000

14:30 US: Producer Prices January PROGNOSE: +0.3% yoy previous: +0.2% yoy Core rate (excluding food and energy) PROGNOSE: +0.3% yoy previous: 0.0% yoy

⬆️⬆️⬆️

- EXANE BNP raises the price target for ALLIANZ SE from EUR 271 to EUR 295. Underperform. $ALV (-0,37 %)

- BARCLAYS raises the target price for AIRBUS from EUR 166 to EUR 200. Overweight. $AIR (-1,99 %)

- UBS raises its price target for SAP from EUR 237 to EUR 283. Buy. $SAP (-2,38 %)

- BERENBERG raises the price target for LVMH from EUR 695 to EUR 720. Buy. $MC (-4,43 %)

- EXANE BNP raises the target price for MUNICH RE from EUR 550 to EUR 560. Outperform. $MUV2 (+0,75 %)

- RBC raises the target price for SIEMENS from EUR 205 to EUR 225. Outperform. $SIE (-7,02 %)

- CITIGROUP raises the price target for STELLANTIS from EUR 12.40 to EUR 13. Neutral. $STLA

- KEPLER CHEUVREUX raises the target price for DOUGLAS from 28.60 EUR to 29.90 EUR. Buy. $DOU (-4,14 %)

- CITIGROUP raises the target price for DWS from EUR 43 to EUR 44.70. Buy. $DWS (-7,3 %)

- CITIGROUP raises the price target for FRAPORT from EUR 62 to EUR 72. Buy. $FRA (-2,64 %)

- UBS upgrades AMADEUS IT from Neutral to Buy and raises target price from EUR 67 to EUR 80. $AMS (-0,21 %)

- DEUTSCHE BANK RESEARCH raises target price for PHILIPS from EUR 25 to EUR 26. Hold. $PHIA (-5,12 %)

- DEUTSCHE BANK RESEARCH raises the target price for MAN GROUP from GBP 2.65 to GBP 2.75. Buy.

- GOLDMAN raises the target price for RIO TINTO from GBP 67 to GBP 73. Buy. $RIO (-1,6 %)

- JEFFERIES raises the price target for SIEMENS ENERGY from EUR 31 to EUR 50. Hold. $ENR (-3,42 %)

- RBC raises the target price for SCHNEIDER ELECTRIC from EUR 195 to EUR 210. $SU (-3,83 %) Underperform.

- EXANE BNP upgrades HANNOVER RÜCK from Neutral to Outperform and raises target price from EUR 265 to EUR 285. $HNR1 (+0,61 %)

⬇️⬇️⬇️

- DEUTSCHE BANK RESEARCH lowers the price target for NOVO NORDISK from DKK 1000 to DKK 900. Buy. $NOVO B (-2,25 %)

- BOFA lowers the target price for RWE from EUR 44 to EUR 42. Buy. $RWE (+1,77 %)

- JPMORGAN lowers the price target for NETFLIX from USD 1010 to USD 1000. Overweight. $NFLX (-1,34 %)

- MORGAN STANLEY lowers the price target for SYMRISE from EUR 137 to EUR 130. Overweight. $SY1 (-1,13 %)

- KEPLER CHEUVREUX lowers the target price for REDCARE PHARMACY from EUR 145 to EUR 138. Hold. $RDC (-0,08 %)

- WARBURG RESEARCH lowers the target price for BECHTLE from EUR 51 to EUR 45. Buy. $BC8 (+0,64 %)

- STIFEL downgrades WACKER CHEMIE from Buy to Hold. $WCH (-5,49 %)

- RBC lowers the price target for DAIMLER TRUCK from EUR 55 to EUR 51. Outperform. $DTG (-4,79 %)